Joanne Davis

Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation

Eric Wong, Joanne Davis, Rachel Koldej, Jeff Szer, Andrew Grigg, David Ritchie

Journal article  |  2019  |  Leukemia & Lymphoma

Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes

Yuhao Jiao, Joanne E Davis, Jai Rautela, Emma M Carrington, Mandy J Ludford-Menting, Wilford Goh, Rebecca B Delconte, Fernando Souza-Fonseca-Guimaraes, Rachel Koldej, Daniel Gray, David Huang, Ben T Kile, Andrew M Lew, David S Ritchie, Nicholas D Huntington

Journal article  |  2019  |  Cell Death & Differentiation

Allogeneic hematopoietic stem cell transplantation (alloSCT) is used to treat over 15,000 patients with acute myeloid leukemia (AM..

Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation

Eric Wong, Joanne E Davis, Andrew Grigg, Jeff Szer, David Ritchie

Journal article  |  2019  |  Bone Marrow Transplantation

Comparison of gene expression and flow cytometry for immune profiling in chronic lymphocytic leukaemia

Chia Sharpe, Joanne Davis, Kylie Mason, Constantine Tam, David Ritchie, Rachel Koldej

Journal article  |  2018  |  Journal of Immunological Methods

Nivolumab for Relapsed or Residual Haematological Malignancies after Allogeneic Haematopoietic Stem Cell Transplantation (NIVALLO)

Eric Wong, Emily Dawson, Joanne Davis, Rachel Koldej, Mandy Ludford-Menting, Matthew Lansdown, Heather Lambie, Jeffrey Szer, Andrew P Grigg, David Ritchie

Conference Proceedings  |  2018  |  Blood

More Than a BTK Inhibitor; Ibrutinib Profoundly Impacts the Function of Cell Mediated Immunity

Chia Sharpe, Joanne Davis, Kylie D Mason, Dale I Godfrey, Adam Uldrich, Constantine S Tam, Rachel Koldej, David Ritchie

Conference Proceedings  |  2018  |  Blood

Pharmacological Control of Recipient NK Cell Function By Venetoclax Promotes Engraftment and Limits GVHD Following Reduced Intensity Conditioning without Impacting the Graft Versus AML Effect

Joanne Davis, Yuhao Jiao, Nicholas Huntington, David Ritchie

Conference Proceedings  |  2017  |  BLOOD

CIK immunotherapy in refractory hematologic malignancies

Eric Wong, David S Ritchie, Joanne E Davis

Journal article  |  2016  |  Leukemia Research

A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in Mice

Joanne E Davis, Michael Harvey, Nicholas A Gherardin, Rachel Koldej, Nicholas Huntington, Paul Neeson, Joseph A Trapani, David S Ritchie

Journal article  |  2015  |  Biology of Blood and Marrow Transplantation

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib

Paul J Neeson, Andy K Hsu, Yin R Chen, Heloise M Halse, Joanna Loh, Reece Cordy, Kate Fielding, Joanne Davis, Josh Noske, Alex J Davenport, Camilla A Lindqvist-Gigg, Robin Humphreys, Tsin Tai, H Miles Prince, Joseph A Trapani, Mark J Smyth, David S Ritchie

Journal article  |  2015  |  OncoImmunology